Cerebrospinal fluid in central nervous system infections

Infections of the Central Nervous System: Fourth Edition

Volumn , Issue , 2014, Pages

  Hasbun, Rodrigo ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84962926682     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (208)

1. Fishman RA. Cerebrospinal Fluid in Diseases of the Nervous System. 2nd ed. Philadelphia: WB Saunders; 1992.
2. Bleck TP, Greenlee JE. Approach to the patient with central nervous system infection. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2000: 950-959.
3. Strazielle N, Ghersi-Egea JF. Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol. 2000;59(7):561-574.
4. Dimattio J, Hochwald GM, Malhan C, et al. Effects of changes in serum osmolality on bulk flow of CSF into cerebral ventricles and on brain water content. Pflugers Arch. 1975;359:253-264.
5. Johanson CE, Palm DE, Dyas ML, et al. Microdialysis analysis of effects of loop diuretics and acetazolamide on chloride transport from blood to CSF. Brain Res. 1994;641:121-126.
6. Welch K. The principles of physiology of the cerebrospinal fluid in relation to hydrocephalus including normal pressure hydrocephalus. In: Friedlander WJ, ed. Advances in Neurology. Current Reviews. New York: Raven Press; 1975:345-375.
7. Yamashima T. Functional ultrastructure of cerebrospinal fluid drainage channels in human arachnoid villi. Neurosurgery. 1988;22:633-641.
8. Krisch B. Ultrastructure of the meninges at the site of penetration of veins through the dura mater, with particular reference to Pacchionian granulations: investigations in the rat and two species of New World monkeys (Cebus apella, Callitrix jacchus). Cell Tissue Res. 1988;251:621-631.
9. Woehrl B, Klein M, Grandgirard D, et al. Bacterial meningitis: current therapy and possible future treatment options. Expert Rev Anti Infect Ther. 2011;9(11):1053-1065.
10. Ellington E, Margolis G. Block of arachnoid villus by subarachnoid hemorrhage. J Neurosurg. 2003;30:651-657.
11. Scheld WM. Bacterial meningitis in the patient at risk. Am J Med. 1984;76(5A):193-207.
12. Simmerkoff MS, Moldover NH, Rahal JJ Jr. Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids: a regional host defense deficiency. J Lab Clin Med. 1980;95: 362-372.
13. Leibowitz S, Hughes RAC. Immunology of the Nervous System. London: Arnold; 1983.
14. Zwahlen A, Nydegger UE, Vaudaux P, et al. Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. J Infect Dis. 1982;145(5):635-646.
15. Partridge WM. Recent advances in blood-brain barrier transport. Annu Rev Pharmacol Toxicol. 1988;28:25-39.
16. Aschner M. Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology. 1998;19(2):269-281.
17. Neal JW, Gasque P. How does the brain limit the severity of inflammation and tissue injury during bacterial meningitis? J Neuropathol Exp Neurol. 2013;72(5):370-385.
18. Titmarsh CJ, Moscovis SM, Hall S, et al. Comparison of cytokine gene polymorphisms among Greek patients with invasive meningococcal disease or viral meningitis. J Med Microbiol. 2013;62(5):694-700.
19. Mook-Kanamori BB, Geldhoff M, van der Poll T, et al. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24(3):557-591.
20. Gloor SM, Wachtel M, Bolliger MF, et al. Molecular and cellular permeability control at the blood-brain barrier. Brain Res Brain Res Rev. 2001;36(2-3):258-264.
21. Fishman RA. Blood-brain and CSF barriers to penicillin and related organic acids. Arch Neurol Psychiatry. 1966;15:113-124.
22. Spector R. The transport of gentamicin in the choroid plexus and cerebrospinal fluid. J Pharmacol Exp Ther. 1975;194(1):82-88.
23. Johnson RT, Johnson KP. Hydrocephalus following viral infection: the pathogenesis of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol. 1968;27:591-606.
24. Timmons GD, Johnson KP. Aqueductal stenosis and hydrocephalus after mumps encephalitis. N Engl J Med. 1970;283:1505-1507.
25. Jaijakul S, Arias CA, Hossain M, et al. Toscana meningoencephalitis: a comparison to other viral central nervous system infections. J Clin Virol. 2012;55(3):204-208.
26. Evans WA. An encephalographic ratio for estimating ventricular and cerebral atrophy. Arch Neurol Psychiatry. 1942;47:931-937.
27. Filippidis A, Kapsalaki E, Patramani G, et al. Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus. 2009;27(5):E3.
28. Bergsneider M. Evolving concepts of cerebrospinal fluid physiology. Neurosurg Clin N Am. 2001;12(4):631-638, vii.
29. Mann JD, Butler AB, Rosenthal JE. Regulation of intracranial pressure in rat, dog, and man. Ann Neurol. 1978;3:156-165.
30. Lundberg N, Cronquist S, Kjallquist A. Clinical investigations on the inter-relationships between intracranial pressure and intracranial hemodynamics. Prog Brain Res. 1968;30:69-81.
31. Plum F, Posner JB. The Diagnosis of Stupor and Coma. 3rd ed. Philadelphia: FA Davis; 1980.
32. Cuneo RA, Caronna JJ, Pitts L, et al. Upward transtentorial herniation: seven cases and a literature review. Arch Neurol. 1979;36(10):618-623.
33. Rebaud P, Berthier JC, Hartemann E, et al. Intracranial pressure in childhood central nervous system infections. Intensive Care Med. 1988;14: 522-525.
34. Goitein KJ, Tamir I. Cerebral perfusion pressure in central nervous system infections of infancy and childhood. J Pediatr. 1983;103:40-43.
35. Thomas K, Hasbun R, Jekel J, et al. The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in patients with suspected meningitis. Clin Infect Dis. 2002;35:46-52.
36. van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849-1859.
37. Korein J, Cravioto H, Leicach M. Reevaluation of lumbar puncture: a study of 129 patients with papilledema or intracranial hypertension. Neurology. 1959;9:290-297.
38. Hasbun R, Abrahams J, Jekel J, et al. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med. 2001;345:1727-1733.
39. Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39(9):1267-1284.
40. Proulx N, Frechette D, Toye D, et al. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM. 2005;98:291-298.
41. Joffe AR. Lumbar puncture and brain herniation in acute bacterial meningitis: a review. J Intensive Care Med. 2007;22:194-207.
42. Domenicucci M, Ramieri A, Ciappetta P, et al. Nontraumatic acute spinal subdural hematoma: report of five cases and review of the literature. J Neurosurg. 1999;91(1)(suppl):65-73.
43. Howard SC, Gajjar A, Ribeiro RC, et al. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA. 2000;284(17):2222-2224.
44. Baer ET. Post-dural puncture bacterial meningitis. Anesthesiology. 2006;105:381-393.
45. Srinivasan V, Gertz RE Jr, Shewmaker PL, et al. Using PCR-based detection and genotyping to trace Streptococcus salivarius meningitis outbreak strain to oral flora of radiology physician assistant. PLoS One. 2012;7(2):e32169.
46. Ahmed SV, Jayawarna C, Jude E. Post lumbar puncture headache: diagnosis and management. Postgrad Med J. 2006;82:713-716.
47. Welch H, Hasbun R. Lumbar puncture and cerebrospinal fluid analysis. Handb Clin Neurol. 2010;96:31-49.
48. Armon C, Evans RW. Addendum to assessment: prevention of post-lumbar puncture headaches. Neurology. 2005;65:510-512.
49. Reina MA, de Leon-Casasola OA, Lopez A, et al. An in vitro study of dural lesions produced by 25-gauge Quincke and Whitacre needles evaluated by scanning electron microscopy. Reg Anesth Pain Med. 2000;25(4):393-402.
50. Norman MG. Respiratory arrest and cervical spinal cord infarction following lumbar puncture in meningitis. Can J Neurol Sci. 1982;9:443-447.
51. Strauss SE, Thorpe KE, Holroyd-Ledu J. How do I perform a lumbar puncture and analyze the result to diagnose bacterial meningitis? JAMA. 2006;296:2012-2022.
52. Ayer JB. Puncture of the cisterna magna. Arch Neurol Psychiatry. 1923;4:529-541.
53. Portela, L, Souza V, Pahl F et al. Laceration of the posterior inferior cerebellar artery by suboccipital puncture of the cisterna magna: case report. Arq Neuropsiquiatr. 2004;62(3b):882-884.
54. van de Beek D, Drake J, Tunkel AR. Nosocomial bacterial meningitis. N Engl J Med. 2010;362(2):146-154.
55. Vidyasagar D, Raju TNK. A simple noninvasive technique of measuring intracranial pressure in the newborn. Pediatrics. 1977;59:957-961.
56. Davis LE. Normal laboratory values of CSF during pregnancy. Arch Neurol. 1979;36:443.
57. Graybill JR, Sobel J, Saag M, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. Clin Infect Dis. 2000;30(1):47-54.
58. Edlow JA, Malek AM, Ogilvy CS. Aneurysmal subarachnoid hemorrhage: update for emergency physicians. J Emerg Med. 2008;34(3):237-251.
59. Walker TJ, Nelson LD, Dunphy BW, et al. Comparative evaluation of the Iris iQ200 body fluid module with manual hemacytometer count. Am J Clin Pathol. 2009;131:333-338.
60. Tunkel AR. Bacterial Meningitis. Philadelphia: Lippincott Williams & Wilkins; 2001.
61. Brouwer M, Thwaites G, Tunkel AR, et al. Dilemmas in the diagnosis of acute community-acquired bacterial meningitis. Lancet. 2012;380: 1684-1692.
62. Mengel M. The use of the cytocentrifuge in the diagnosis of meningitis. Am J Clin Pathol. 1985;84:212-216.
63. Cinque P, Linde A. CSF Analysis in the diagnosis of viral encephalitis and meningitis. In: Nath A, Berger JR, eds. Clinical Neurovirology. New York: Marcel Dekker; 2003.
64. Rice SK, Heinl RE, Thornton LL, et al. Clinical characteristics, management strategies, and cost implication of a statewide outbreak of enterovirus meningitis. Clin Infect Dis. 1995;20:931-937.
65. Marra CM, Tantalo LC, Maxwell CL, et al. Alternative cerebrospinal fluid tests to diagnose neurosyphilis in HIV-infected individuals. Neurology. 2004;63(1):85-88.
66. Graeff-Teixeira C, Arámburu da Silva AC, Yoshimura K. Update on eosinophilic meningoencephalitis and its clinical relevance. Clin. Microbiol Rev. 2009;22(2):322-348.
67. Matthews WF, Frohmeyer WB Jr. The in vitro behavior of erythrocytes in human cerebrospinal fluid. J Lab Clin Med. 1955;45:508-515.
68. Meyer GC, Netsky MG. Relation of blood and cerebrospinal fluid glucose. Arch Neurol Psychiatry. 1962;6:18-20.
69. Swartz MN, Dodge PR. Bacterial meningitis-a review of selected aspects 1. General clinical features, special problems, and unusual meningeal reactions mimicking bacterial meningitis. N Engl J Med. 1965;272: 779-787.
70. Ellner JJ, Bennett JE. Chronic meningitis. Medicine. 1976;55:341-369.
71. Hasbun R. The acute aseptic meningitis. Cur Infect Dis Rep. 2000;2(4): 345-351.
72. Tsiodras S, Kelesidis I, Kelesidis T. et al. Central Nervous system manifestations of Mycoplasma pneumoniae infections. J Infect. 2005;51(5): 343-354.
73. Sharma OP. Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest. 1997;112(1):220-228.
74. Zeller JA, Zunker P, Witt K, et al. Unusual presentation of carcinomatous meningitis: case report and review of typical CSF findings. Neurol Res. 2002;24(7):652-654.
75. Pasquier F, Leys D, Vermersch P, et al. Severe hypoglycorrhachia after subarachnoid hemorrhage: two cases with spontaneous recovery in adults. Acta Neurol Belg. 1987;87(2):76-79.
76. Valmari P, Peltola H, Kataja M. Cerebrospinal fluid white cell, glucose and protein changes during the treatment of Haemophilus influenzae meningitis. Scand J Infect Dis. 1986;18(1):39-43.
77. Roine I, Foncea LM, Ledermann W, et al. Slow recovery of cerebrospinal fluid glucose and protein concentrations distinguish pneumococcal from Haemophilus influenzae and meningococcal meningitis in children. Pediatr Infect Dis J. 1995;14(10):905-907.
78. Silver TS, Todd JK. Hypoglycorrhachia in pediatric patients. Pediatrics. 1976;58:67-71.
79. Omene JA, Okolo AA, Longe AC, et al. The specificity and sensitivity of CSF and blood glucose concentration in the diagnosis of neonatal meningitis. Ann Trop Paediatr. 1985;5(1):37-39.
80. Powers WJ. Cerebrospinal fluid to serum glucose ratios in diabetes mellitus and bacterial meningitis. Am J Med. 1981;71(2):217-220.
81. Spanos A, Harrell FE, Durack DT. Differential diagnosis of acute meningitis, an analysis of the predictive value of initial observations. JAMA. 1989;262:2700-2707.
82. Khoury N, Hossain M, Wootton S, et al. Meningitis with a negative cerebrospinal fluid Gram stain in adults: risk classification for an adverse clinical outcome. Mayo Clin Proc. 2012;87(12):1181-1188.
83. Quagliarello VJ, Ma A, Stukenbrok H, et al. Ultrastructural localization of albumin transport across the cerebral microvasculature during experimental meningitis in the rat. J Exp Med. 1991;174(3):657-672.
84. Nigrovic LE, Malley R, Macias CG, et al. Effect of antibiotic pretreatment on cerebrospinal fluid profiles of children with bacterial meningitis. Pediatrics. 2008;122(4):726-730.
85. Kelly SB, Kinsella K, Duggan M, et al. A proposed modification to the McDonald 2010 criteria for the diagnosis of primary progressive multiple sclerosis. Mult Scler. 2013;19(8):1095-1100.
86. Flitch MF, van de Beek D. Emergency diagnosis and treatment of adult meningitis. Lancet Infect Dis. 2007;7:191-200.
87. Kleiman MB, Reynolds JK, Watts NH, et al. Superiority of acridine orange stain versus Gram stain in partially treated bacterial meningitis. J Pediatr. 1984;104(3):401-404.
88. Genne D, Siegrist HH, Lienhard R. Enhancing the etiologic diagnosis of community-acquired pneumonia in adults using the urinary antigen assay (Binax NOW). Int J Infect Dis. 2006;10:124-128.
89. Marcos MA, Martinez E, Almela M, et al. New rapid antigen test for diagnosis of pneumococcal meningitis. Lancet. 2001;357:1499-1500.
90. Samra Z, Schmuely H, Nahum E, et al. Use of the NOW Streptococcus pneumoniae urinary antigen test in cerebrospinal fluid for rapid diagnosis of pneumococcal meningitis. Diagn Microbiol Infect Dis. 2003;45: 237-240.
91. Moïsi JC, Saha SK, Adegoke G., et al. Enhanced diagnosis of pneumococcal meningitis using the Binax NOW S. pneumoniae immuno-chromatographic test: a multi-site study. Clin Infect Dis. 2009;48(suppl 2): S49-S56.
92. Gray F, Alonso JM. Bacterial infections of the central nervous system. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. 7th ed. London: Arnold; 2002;151-193.
93. Karcher D, Mc Pherson R. Cerebrospinal fluid, synovial, serous body fluids and alternative specimens. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia: WB Saunders; 2011:480-508.
94. Thomson RB Jr, Bertram H. Laboratory diagnosis of central nervous system infections. Infect Dis Clin North Am. 2001;15:1047-1071.
95. Katti MK. Pathogenesis, diagnosis, treatment, and outcome aspects of cerebral tuberculosis. Med Sci Monit. 2004;10:RA215-RA229.
96. Thakur R, Goyal R, Sarma S. Laboratory diagnosis of tuberculous meningitis-is there a scope for further improvement? J Lab Physicians. 2010;2(1):21-24.
97. Rikihisa Y. Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells. Nat Rev Microbiol. 2010;8(5):328-339.
98. Tunkel A. Bacterial Meningitis. Philadelphia: Lippincot Williams & Wilkins; 2001:142-148.
99. McMullan BJ, Halliday C, Sorrell TC, et al. Clinical utility of cryptococcal antigen lateral flow assay in a diagnostic mycology laboratory. PLoS One. 2012;7(11):e49541.
100. Singh U, Petri WA Jr. Free-living amebas. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. Philadelphia: Churchill Livingstone; 2000:2811-2817.
101. White MH. Cryptococcosis. Inf Dis Clin North Am. 1994;8:383-398.
102. Fernandez M, Moylett EH, Noyola DE, et al. Candidal meningitis in neonates: a 10-year review. Clin Infect Dis. 2000;31(2):458-463.
103. Andrew R, Craig D, Woods M. Fungal infections of the central nervous system: a review of fungal pathogens and treatments. Neur Ind. 2007;55(3): 251-259.
104. Chonmaitree T, Baldwin CD, Lucia HL. Role of the virology laboratory in diagnosis and management of patients with central nervous system disease. Clin Microbial Rev. 1989;2:1-14.
105. Storch GA. The diagnosis of viral infections. Infect Dis Clin Pract. 1993;2:1-20.
106. Campbell GL, Marfin AA, Lanciotti RS, et al. West Nile virus. Lancet Infect Dis. 2002;2:1-16.
107. Huy NT, Thao NT, Diep DT, et al. Cerebrospinal fluid lactate concentration to distinguish bacterial from aseptic meningitis: a systemic review and meta-analysis. Crit Care. 2010;14:R240.
108. Sakushima K, Hayashino Y, Kawaguchi T, et al. Diagnostic accuracy of cerebrospinal fluid lactate for differentiating bacterial meningitis from aseptic meningitis: a meta-analysis. J Infect. 2011;62:255-262.
109. Ray P, Badarou-Acossi G, Viallon A, et al. Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear. Am J Emerg Med. 2007;25: 179-184.
110. Sormunen P, Kallio MJ, Kilpi T, et al. C-reactive protein is useful in distinguishing Gram-stain negative bacterial meningitis from viral meningitis in children. J Pediatr. 1999;134:725-729.
111. Dubos F, Korczowski B, Aygun DA, et al. Serum procalcitonin level and other biomarkers to distinguish between bacterial meningitis and aseptic meningitis: a meta-analysis. J Infect. 2011;62:255-262.
112. Taskin E, Turgot M, Kilic M, et al. Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis. Mediators Inflamm. 2004;13:269-273.
113. Ernst A, Morgenthaler NG, Buerger K, et al. Procalcitonin is elevated in the cerebrospinal fluid of patients with dementia and acute neuroinflammation. J Neuroimmunol. 2007;189:169-174.
114. Mein J, Lum G. CSF bacterial antigen detection tests offer no advantage over Gram's stain in the diagnosis of bacterial meningitis. Pathology. 1999;31(1):67-69.
115. Perkins MD, Mirrett S, Reller LB. Rapid bacterial antigen detection is not clinically useful. J Clin Microbiol. 1995;33(6):1486-1491.
116. Hasbun R, Bijlsma M, Brouwer MC, et al. Risk score for identifying adults with CSF pleocytosis and negative CSF Gram stain at low risk for an urgent treatable cause. J Infect. 2013;67(2):102-110.
117. DeBiasi RL, Tyler KL. Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev. 2004;17:903-925.
118. Yamamoto Y. PCR in diagnosis of infection: detection of bacteria in cerebrospinal fluids. Clin Diagn Lab Immunol. 2002;9:508-514.
119. Desai D, Nataraj G, Kulkarni S, et al. Utility of the polymerase chain reaction in the diagnosis of tuberculous meningitis. Res Microbiol. 2006;157:967-970.
120. Parent du Chatelet I, Traoere Y, Gessner BD, et al. Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing. Clin Infect Dis. 2005;40:17-25.
121. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006;71:141-148.
122. Roos KL. Encephalitis. Neurol Clin. 1999;17:813-833.
123. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303-327.
124. Kost C, Rogers B, Oberste S, et al. Multicenter beta trial of the GeneXpert enterovirus assay. J Clin Microbiol. 2007;45(4):1081-1086.
125. Rafi W, Venkataswamy MM, Nagarathna S, et al. Role of IS6110 uniplex PCR in the diagnosis of tuberculous meningitis: experience at a tertiary neurocentre. Int J Tuberc Lung Dis. 2007;11:209-213.
126. Nguyen LA, Kox LFF, Pham LD, et al. The potential contribution of the polycerase chain reaction to the diagnosis of tuberculous meningitis. Arch Neurol. 1996;53:771-776.
127. Takahashi T, Tamura M, Takasu T. The PCR-based diagnosis of central nervous system tuberculosis: up to date. Tuberc Res Treat. 2012;2012:831292.
128. Choi SH, Kim YS, Bae IG, et al. The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults. Clin Neurol Neurosurg. 2002;104(1):10-15.
129. Lopez-Cortes LF, Cruz-Ruiz M, Gomez-Mateos J, et al. Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis or neurobrucellosis. Clin Infect Dis. 1995;20(3):525-530.
130. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the second national conference on serological diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep. 1995;44:590.
131. Dattwyler RJ, Volkman DJ, Luft BJ, et al. Seronegative Lyme disease: dissociation of specific T-and B-lymphocyte responses to Borrelia burgdorferi. N Engl J Med. 1988;319(22):1441-1446.
132. Kaiser R. Neuroborreliosis. J Neurol. 1998;245(5):247-255.
133. Steere AC, Berardi VP, Weeks KE, et al. Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis. J Infect Dis. 1990;161:1203-1209.
134. Halperin JJ, Luft BJ, Anand AK, et al. Lyme neuroborreliosis: central nervous system manifestations. Neurology. 1989;39(6):753-759.
135. Tylewska-Wierzbanowska S, Chmielewski T. Limitation of serological testing for Lyme borreliosis: evaluation of ELISA and western blot in comparison with PCR and culture methods. Wien Klin Wochenschr. 2002;114(13-14):601-605.
136. Nolte O. Nucleic acid amplification based diagnostic of Lyme (neuro-) borreliosis-lost in the jungle of methods, targets, and assays? Open Neurol J. 2012;6:129-139.
137. Reed KD. Laboratory testing for Lyme disease: possibilities and practicalities. J Clin Microbiol. 2002;40(2):319-324.
138. Zbinden R, Goldenberger D, Lucchini GM, et al. Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis. J Clin Microbiol. 1994;32(7):1795-1798.
139. Christen HJ, Eiffert H, Ohlenbusch A, et al. Evaluation of the polymerase chain reaction for the detection of Borrelia burgdorferi in cerebrospinal fluid of children with acute peripheral facial palsy. Eur J Pediatr. 1995;154(5):374-377.
140. Bremell D, Mattsson N, Edsbagge M, et al. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol. 2013;13:1471-2377.
141. Currie BP, Freundlich LF, Soto MA, et al. False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis. J Clin Microbiol. 1993;31(9): 2519-2522.
142. Berlin L, Pincus JH. Cryptococcal meningitis: false-negative antigen test results and cultures in nonimmunosuppressed patients. Arch Neurol. 1989;46(12):1312-1316.
143. Jarvis JN, Percival A, Bauman S, et al. Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis. Clin Infect Dis. 2011;53: 1019-1023.
144. Roy M, Chiller T. Preventing deaths in cryptococcal meningitis: from bench to bedside. Expert Rev Anti Infect Ther. 2011;9(9):715-717.
145. Bouza E, Dreyer JS, Hewitt WL, et al. Coccidioidal meningitis: an analysis of thirty-one cases and review of the literature. Medicine (Baltimore). 1981;60(3):139-172.
146. Williams PL, Johnson R, Pappagianis D, et al. Vasculitic and encephalitic complications associated with Coccidioides immitis infection of the central nervous system in humans: report of 10 cases and review. Clin Infect Dis. 1992;14(3):673-682.
147. Wheat LJ, Kohler RB, Tewari RP, et al. Significance of Histoplasma antigen in the cerebrospinal fluid of patients with meningitis. Arch Intern Med. 1989;149(2):302-304.
148. Wheat LJ, Batteiger BE, Sathapatayavongs B. Histoplasma capsulatum infections of the central nervous system: a clinical review. Medicine (Baltimore). 1990;69(4):244-260.
149. Wheat LJ, Musial CE, Jenny-Avital E. Diagnosis and management of central nervous system histoplasmosis. Clin Infect Dis. 2005;40: 844-852.
150. Lindsley MD, Hurst SF, Iqbal NJ, et al. Rapid identification of dimorphic and yeast-like fungal pathogens using specific DNA probes. J Clin Microbiol. 2001;39(10):3505-3511.
151. Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;185(suppl 1):S73-S82.
152. Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1993;329:995-1000.
153. Potasman I, Resnick L, Luft BJ, et al. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988;108(1):49-51.
154. Alfonso Y, Fraga J, Cox R, et al. Conventional polymerase chain reaction for the diagnosis of neurotoxoplasmosis: comparison of three sets of primers for the B1 gene using CSF samples. Diag Microb and Infect Dis. 2013;75(2):150-154.
155. Sukthana Y, Mahittikorn A, Wickert H, et al. A promising diagnostic tool for toxoplasmic encephalitis: tachyzoite/bradyzoite stage-specific RT-PCR. Int J Infect Dis. 2012;16:e279-e284.
156. Gerard A, Sarrot-Reynauld F, Liozon E, et al. Neurologic presentation of Whipple disease: report of 12 cases and review of the literature. Medicine (Baltimore). 2002;81(6):443-457.
157. Raoult D, Birg ML, La Scola B, et al. Cultivation of the bacillus of Whipple's disease. N Engl J Med. 2000;342(9):620-625.
158. von Herbay A, Ditton HJ, Schuhmacher F, et al. Whipple's disease: staging and monitoring by cytology and polymerase chain reaction analysis of cerebrospinal fluid. Gastroenterology. 1997;113(2): 434-441.
159. Fenollar F, Fournier PE, Raoult D, et al. Quantitative detection of Tropheryma whipplei DNA by real-time PCR. J Clin Microbiol. 2002;40(3):1119-1120.
160. Puccioni-Sohler M, Rios M, Carvalho SM, et al. Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index. Neurology. 2001;57(4):725-727.
161. Sauerbrei A, Eichhorn U, Hottenrott G, et al. Virological diagnosis of herpes simplex encephalitis. J Clin Virol. 2000;17(1):31-36.
162. Murray K, Mertens E, Despress P. West Nile virus and its emergence in the United States. Vet Res. 2010;41(6):67.
163. Ramers C, Billman G, Hartin M, et al. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA. 2000;283(20):2680-2685.
164. Robinson CC, Willis M, Meagher A, et al. Impact of rapid polymerase chain reaction results on management of pediatric patients with enteroviral meningitis. Pediatr Infect Dis J. 2002;21(4):283-286.
165. Rotbart HA, Sawyer MH, Fast S, et al. Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay. J Clin Microbiol. 1994;32(10):2590-2592.
166. Guffond T, Dewilde A, Lobert PE, et al. Significance and clinical relevance of the detection of herpes simplex virus DNA by the polymerase chain reaction in cerebrospinal fluid from patients with presumed encephalitis. Clin Infect Dis. 1994;18(5):744-749.
167. Cinque P, Cleator GM, Weber T, et al. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis. J Neurol Neurosurg Psychiatry. 1996;61(4):339-345.
168. Fodor PA, Levin MJ, Weinberg A, et al. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology. 1998;51(2):554-559.
169. Read SJ, Kurtz JB. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J Clin Microbiol. 1999;37(5):1352-1355.
170. Kleinschmidt-DeMasters BK, Gilden DH. Varicella-Zoster virus infections of the nervous system: clinical and pathologic correlates. Arch Pathol Lab Med. 2001;125(6):770-780.
171. Bestetti A, Pierotti C, Terreni M, et al. Comparison of three nucleic acid amplification assays of cerebrospinal fluid for diagnosis of cytomegalovirus encephalitis. J Clin Microbiol. 2001;39(3):1148-1151.
172. Weinberg A, Li S, Palmer M, et al. Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol. 2002;53: 543-548.
173. Garcia de Viedma D, Alonso R, Miralles P, et al. Dual qualitative-quantitative nested PCR for detection of JC virus in cerebrospinal fluid: high potential for evaluation and monitoring of progressive multifocal leukoencephalopathy in AIDS patients receiving highly active antiretroviral therapy. J Clin Microbiol. 1999;37(3):724-728.
174. Briese T, Glass WG, Lipkin WI. Detection of West Nile virus sequences in cerebrospinal fluid. Lancet. 2000;355(9215):1614-1615.
175. Lanciotti RS, Kerst AJ. Nucleic acid sequence-based amplification assays for rapid detection of West Nile and St. Louis encephalitis viruses. J Clin Microbiol. 2001;39(12):4506-4513.
176. Bociaga-Jasik M, Garlicki A, Cies'la A, et al. The diagnostic value of cytokine and nitric oxide concentrations in cerebrospinal fluid for the differential diagnosis of meningitis. Adv Med Sci. 2012;57(1):142-147.
177. Mukai AO, Krebs VL, Bertoli CJ, et al. TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children. Pediatr Neurol. 2006;34(1):25-29.
178. Lopez-Cortes LF, Marquez-Arbizu R, Jimenez-Jimenez LM, et al. Cerebrospinal fluid tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and interleukin-8 as diagnostic markers of cerebrospinal fluid infection in neurosurgical patients. Crit Care Med. 2000;28(1):215-219.
179. Pinto Junior VL, Rebelo MC, Gomes RN, et al. IL-6 and IL-8 in cerebrospinal fluid from patients with aseptic meningitis and bacterial meningitis: their potential role as a marker for differential diagnosis. Braz J Infect Dis. 2011;15(2):156-158.
180. Tang RB, Lee BH, Chung RL, et al. Interleukin-1 beta and tumor necrosis-alpha in cerebrospinal fluid of children with bacterial meninigitis. Childs Nerv Syst. 2001;17(8):453-486.
181. Powers WJ. Cerebrospinal fluid lymphocytosis in acute bacterial meningitis. Am J Med. 1985;79:216-220.
182. Brouwer MC, van de Beek D, Sebastiaan G. B., et al. Community-acquired Listeria monocytogenes meningitis in adults. Clin Infect Dis. 2006;43(10):1233-1238.
183. Bonadio WA. Acute bacterial meningitis: cerebrospinal fluid differential count. Clin Pediatr (Phila). 1988;27(9):445-447.
184. Fishbein DB, Palmer DL, Porter KM, et al. Bacterial meningitis in the absence of CSF pleocytosis. Arch Intern Med. 1981;141(10):1369-1372.
185. Jim KK, Brouwer MC, van der Ende, et al. Subdural empyema in bacterial meningitis. Neurology. 2012;79(21):2133-2139.
186. Tattevin P, Bruneel F, Régnier B. Cranial CT before lumbar puncture in suspected meningitis. N Engl J Med. 2002;346(16):1248-1251.
187. King N. Brain abscess. In: Roos KL, Tunkel AR, eds. Handbook of Clinical Neurology: Bacterial Infections of the Central Nervous System. Amsterdam: Elsevier; 2010:65-74.
188. Helweg-Larsen J, Astradsson A, Richhall H, et al. Pyogenic brain abscess, a 15 year survey. BMC Infect Dis. 2012;12:332.
189. Thwaites G, Fisher M, Hemingway C, et al. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. J of Infect. 2009;59:167-187.
190. Panther LA, Sande MA. Cryptococcal meningitis in the acquired immunodeficiency syndrome. Semin Respir Infect. 1990;5(2):138-145.
191. Lehrer RI, Hoard DH, Sypherd PS, et al. Mucormycosis. Ann Intern Med. 1980;93:93-108.
192. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis. 2004;189(3):369-374.
193. Ho EL, Marra CM. Treponemal tests for neurosyphilis-less accurate than what we thought? Sex Trasnm Dis. 2012;39(4):298-299.
194. Marra CM, Tantalo LC, Maxwell CL, et al. The rapid regain test cannot replace the venereal disease research laboratory test for neurosyphilis. Sex Transm Dis. 2012;39(6):453-457.
195. Peng R-R, Wang AL, Li J, et al. Molecular typing of Treponema pallidum: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2011;5(11):e1273.
196. Cohn K, Thompson AD, Shah S, et al. Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Pediatrics. 2012;129(1):e46-e53.
197. Miller JQ, Price TR. The nervous system in Rocky Mountain spotted fever. Neurology. 1972;22:561-566.
198. Massung RF, Davis LE, Slater K, et al. Epidemic typhus meningitis in the southwestern United States. Clin Infect Dis. 2001;32:979-982.
199. St Clair K, Decker CF. Ehrlichioses: anaplasmosis and human ehrlichiosis. Dis Mon. 2012;58:346-354.
200. Feigin RD, Shackleford PG. Value of repeat lumbar puncture in the differential diagnosis of meningitis. N Engl J Med. 1973;289:571-574.
201. Varki AP, Puthuran P. Value of second lumbar puncture in confirming a diagnosis of aseptic meningitis. Arch Neurol. 1979;36:581-582.
202. Negrini B, Kelleher KJ, Wald ER. Cerebrospinal fluid findings in aseptic versus bacterial meningitis. Pediatrics. 2000;105(2):316-319.
203. Henquell C, Chambon M, Bailly JL, et al. Prospective analysis of 61 cases of enteroviral meningitis: interest of systematic genome detection in cerebrospinal fluid irrespective of cytologic examination results. J Clin Virol. 2001;21(1):29-35.
204. Brenton DW. Hypoglycorrhachia in herpes simplex type 2 meningitis. Arch Neurol. 1980;37:317.
205. Reimer LG, Beller LB. CSF in herpes zoster meningoencephalitis. Arch Neurol. 1981;38(10):668.
206. Churchill M, Nath A. Where does HIV hide? A focus on the central nervous system. Curr Opn HIV AIDS. 2013;8:165-169.
207. Hamlin C, Puoti G, Berri S, et al. A comparison of tau and 1433 protein in the diagnosis of Creuktzfeldt-Jakob disease. Neurology. 2012;79(6):547-552.
208. Koehler AP, Athan E, Collins SJ. Updated Creutzfeldt-Jakob disease infection control guidelines: sifting facts from fiction. Med J Aust. 2013;70(2):245-246.